학술논문
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry
Document Type
Article
Author
Kutsch, N.; Giza, A.; Robrecht, S.; Stumpf, J.; Federhen, A.; Fischer, K.; Eichhorst, B.; Hallek, M.; Fink, A.M.; Stoltefuß, A.; Vehling-Kaiser, U.; Koenigsmann, M.; Tausch, E.; Schneider, C.; Stilgenbauer, S.; Illmer, T.; Schlag, R.; Dörfel, S.; Gaska, T.; Kiehl, M.; Müller-Hagen, S.; Moorahrend, E.; Linde, H.; Schlenska-Lange, A.; von Tresckow, J.
Source
In: European Journal of Haematology . (European Journal of Haematology, August 2024, 113(2):235-241)
Subject
Language
English
ISSN
16000609
09024441
09024441